TrialAntimicrobial agents and chemotherapy2017

A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance.

Feng-Woei Tsay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.